Cross-Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

Background. Avian H5N1 influenza A virus is an emerging pathogen with the potential to cause substantial human morbidity and mortality. We evaluated the ability of currently licensed seasonal influenza vaccine to confer cross-protection against highly pathogenic H5N1 influenza virus in mice. Methods...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Ichinohe, Takeshi, Tamura, Shin-ichi, Kawaguchi, Akira, Ninomiya, Ai, Imai, Masaki, Itamura, Shigeyuki, Odagiri, Takato, Tashiro, Masato, Takahashi, Hidehiro, Sawa, Hirofumi, Mitchell, William M., Strayer, David R., Carter, William A., Chiba, Joe, Kurata, Takeshi, Sata, Tetsutaro, Hasegawa, Hideki
Formato: Artigo
Idioma:Inglês
Publicado em: The University of Chicago Press 2007
Assuntos:
Major Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7110255/
https://ncbi.nlm.nih.gov/pubmed/17922395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/521304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados